Developing new treatments for kidney diseases
Official title: University of Michigan O'Brien Kidney Translational Resource Center (MKTC)
Funded at University of Michigan at Ann Arbor · NIH-10914996 · Data updated 2026-11-12
The University of Michigan is working on new ways to help people with kidney diseases by studying the tiny details of how these conditions happen, so they can find better treatments and improve health outcomes for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $937,567 |
| NIH project number | 5U54DK137314-02 |
| Project ID | NIH-10914996 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with acute or chronic kidney diseases.
✕Less likely to help
Patients with kidney diseases that are not acute or chronic may not benefit from this research.
What this research studies
The University of Michigan O'Brien Kidney Translational Resource Center focuses on creating innovative treatment strategies for patients suffering from kidney diseases. This research utilizes advanced systems biology techniques to explore the molecular causes of both acute and chronic kidney conditions. By integrating data from various biological sources, the center aims to identify new biomarkers and treatment targets that can lead to improved patient outcomes. The center supports researchers in their efforts to translate these findings into practical therapies for patients.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for kidney diseases, improving the quality of life for patients.
How similar studies have gone: Other research initiatives using systems biology approaches have shown promise in advancing treatment strategies for complex diseases, indicating potential success for this approach.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Pennathur, Subramaniam — University of Michigan at Ann Arbor
- Study coordinator: Pennathur, Subramaniam
Related research
Other NIH-funded projects on the same topics.
-
Expanding genetic testing for cancer risk in patients and families
This study is working to make it easier for cancer patients in Michigan to get genetic testing for cancer risk by improving how doctors gather family history and assess genetic risks, so that more people can receive the important evaluations they need.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Why the retina can sometimes heal itself and how we might help it heal
This NIH grant explores how inflammation and neural cells interact in the zebrafish retina to understand retinal neuron death and regeneration, with potential implications for human vision.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.